Oral and Inhaled Fosamprenavir Reverses Pepsin-Induced Damage in a Laryngopharyngeal Reflux Mouse Model.
Nikki JohnstonTina L SamuelsChristopher J GoetzLeggy A ArnoldBrian C SmithDonna SeabloomBeverly WuertzFrank G OndreyTimothy S WiedmannNemanja VuksanovicNicholas R SilvaggiAlexander C MacKinnonJames MillerJonathan M BockJoel H BluminPublished in: The Laryngoscope (2022)
NA. Laryngoscope, 2022.